Zum Inhalt springen
Home » FDA Safety Communication

FDA Safety Communication

The FDA is announcing a recall initiated by Cardinal Health related to the Jiangsu Shenli Medical Production Co Ltd. recall to stop using its unauthorized plastic syringes. Cardinal Health recalled affected kits that contain Merit Medical kits with Jiangsu Shenli syringes.

On June 14, 2024, the FDA  announced a recallExternal Link Disclaimer initiated by Merit Medical Systems, Inc. in direct response to the Jiangsu Shenli Medical Production Co Ltd. recall to stop using its unauthorized plastic syringes. Merit includes the affected Jiangsu Shenli syringes in multiple kits.

LabNews Media LLC

LabNews Media LLC

The Editors in Chief of lab-news.de are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu